iPSC & Stem Cell Culture — Serum and Xeno-Free Media Selection Guide
iPSCs and ESCs are the foundation of disease modelling, drug screening, and cell therapy manufacturing. iPSC technology is converging with CAR-T and gene therapy — iPSC-derived CAR-T cells offer off-the-shelf allogeneic cell therapy at industrial scale. Every stem cell programme requires carefully selected serum or serum-free supplements — the wrong grade compromises pluripotency, introduces xenogenic contamination, or fails to support directed differentiation.
FBS ES Cell Pre-Tested
Lot-screened for Oct4, Sox2, Nanog expression and spontaneous differentiation rate <5% per passage. The only appropriate FBS grade for ESC/iPSC feeder-dependent maintenance.
Donor Horse Serum (DHS)
Standard supplement for hematopoietic CFU assays (CFU-GM, BFU-E) in methylcellulose medium. Provides unique lipid and growth factor composition that FBS cannot replicate for myeloid/erythroid progenitor expansion.
rHSA Premium Grade — Xeno-Free
Recombinant HSA for xeno-free and GMP iPSC protocols — defined albumin without donor variability. For chemically defined maintenance media (mTeSR, E8), cryopreservation, and iPSC-CAR-T expansion.
Human Serum AB OTC Male — iPSC-CAR-T
iPSC-derived T cell products require human serum for final T cell expansion and activation — same EMA/410/01 requirements as primary CAR-T manufacturing. AB type, male donors, off-the-clot.
Why standard FBS fails in iPSC culture
Standard FBS contains undefined bioactive components — particularly bone morphogenetic proteins (BMPs), activin, and other TGF-β superfamily members — that activate differentiation signalling in pluripotent stem cells. Lot-to-lot variation in these factors means that some standard FBS lots are completely incompatible with ESC/iPSC maintenance, causing rapid spontaneous differentiation within 1–2 passages.
FBS ES Cell Pre-Tested lots are individually screened in ESC culture before release. Screening criteria include: maintenance of Oct4, Sox2, Nanog, and SSEA-4 expression after 5–7 days of culture; compact dome-shaped colony morphology; spontaneous differentiation rate <5% of cells per passage; and normal karyotype maintenance over at least 10 passages.
For modern feeder-free protocols (mTeSR1, E8), serum is eliminated entirely — replaced by chemically defined growth factors (FGF2, TGF-β1, insulin, transferrin, ascorbic acid). In these systems, rHSA serves as the albumin carrier for lipids and growth factor stabilisation, replacing bovine albumin with a defined, lot-consistent animal-free alternative.
Batch reservation for iPSC programmes: iPSC reprogramming and long-term maintenance programmes can run for 12–36 months. A serum lot change mid-programme can shift culture conditions enough to alter karyotypic stability and epigenetic state. SeamlessBio holds reserved FBS ES Cell Pre-Tested lots for up to 12 months — ensuring consistency from initial reprogramming through the full iPSC characterisation and banking workflow.
Recommended products
- FBS ES Cell Pre-Tested — feeder-dependent ESC/iPSC maintenance
- Donor Horse Serum (DHS) — CFU-GM, BFU-E hematopoietic assays
- rHSA Premium Grade — GMP xeno-free maintenance and cryo
- rHSA Economy Grade — research-scale serum-free media
- Human Serum AB OTC Male — iPSC-CAR-T T cell expansion
- Human Platelet Lysate (hPL) — xeno-free MSC expansion
Serum Requirements by Stem Cell Application
| Application | Recommended Product | Why |
|---|---|---|
| ESC / iPSC maintenance on feeder cells | FBS ES Cell Pre-Tested — 15–20% in DMEM/F12 or KnockOut DMEM | Lot-tested for Oct4, Sox2, Nanog expression. Spontaneous differentiation <5% per passage. Colony morphology validated. |
| MEF feeder cell preparation | FBS ES Cell Pre-Tested — 10% for MEF expansion | Consistent feeder cell quality requires consistent FBS — ES Cell Pre-Tested ensures MEF morphology and support function reproducibility. |
| Feeder-free iPSC culture (mTeSR, E8) | Serum-free defined medium + rHSA Premium if required | Chemically defined protocols eliminate serum entirely. rHSA provides albumin without donor variability for xeno-free systems. |
| Embryoid body (EB) formation | FBS ES Cell Pre-Tested — 20% in IMDM or DMEM | EB formation requires serum for spontaneous multi-lineage differentiation. ES Cell Pre-Tested provides defined starting conditions. |
| Hematopoietic differentiation | Donor Horse Serum (DHS) — 15–30% in methylcellulose | DHS is specified in StemCell Technologies MethoCult protocols for CFU-GM and BFU-E colony formation. FBS does not provide equivalent myeloid/erythroid support. |
| Neural differentiation | Serum-free (N2/B27) ± rHSA as protein stabiliser | Serum drives astrocyte differentiation and blocks neuronal specification — neural protocols are serum-free by requirement. |
| Cardiac differentiation (cardiomyocytes) | FBS ES Cell Pre-Tested — 20% in early EB stage; serum-free from day 5 | CHIR99021/Wnt activation protocol requires defined serum in early stage. Serum-free from day 5 for cardiomyocyte specification. |
| iPSC-CAR-T manufacturing | Human Serum AB Male OTC for T cell expansion | iPSC-derived T cells require human serum for final expansion — same EMA/410/01 requirements as primary CAR-T manufacturing. |
| GMP iPSC manufacturing | Xeno-free serum-free + rHSA Premium Grade | Regulatory standard for clinical-grade iPSC — no animal-derived components. rHSA provides defined albumin supplementation. |
FBS ES Cell Pre-Tested vs Standard FBS — What Makes It Different
| Parameter | Standard FBS | FBS ES Cell Pre-Tested |
|---|---|---|
| Pluripotency testing | Not tested | ✅ Oct4, Sox2, Nanog expression validated per lot |
| Spontaneous differentiation rate | Variable — can be >20% per passage | ✅ ≤5% per passage — lot specification |
| Colony morphology | Not assessed | ✅ Compact dome-shaped colony morphology validated |
| Growth factor profile | Undefined — lot-to-lot variable | Lot-selected for LIF-independent pluripotency support |
| Endotoxin | Variable — can drive differentiation | Low endotoxin — LPS activates BMP/differentiation signalling |
| Batch reservation | Standard | ✅ Extended reservation — multi-year iPSC programmes |
| Documentation | CoA standard | ✅ Pluripotency test report + CoA + batch data per lot |
Donor Horse Serum (DHS) for Hematopoietic Assays
Donor Horse Serum collected from adult horses via regular donation (not terminal bleed) is the standard supplement for hematopoietic colony-forming unit (CFU) assays and myeloid differentiation protocols. DHS provides a unique growth factor and lipid composition that supports erythroid and myeloid progenitor expansion in ways that FBS cannot replicate — it is specifically named in StemCell Technologies MethoCult published protocols.
| Application | DHS Concentration | Protocol Note |
|---|---|---|
| CFU-GM assay (myeloid progenitors) | 15–30% in methylcellulose medium | Standard StemCell Technologies MethoCult protocol — DHS specified as serum source for myeloid colony formation |
| BFU-E assay (erythroid progenitors) | 15–30% in methylcellulose | Erythropoietin-stimulated BFU-E colony formation — DHS provides lipid factors for haemoglobin synthesis in erythroid progenitors |
| iPSC hematopoietic differentiation | 10–20% in differentiation medium | Stage-specific use during myeloid specification from iPSC-derived hemogenic endothelium |
| Bone marrow stromal cell support | 10–15% in stromal culture medium | MSC and stromal cell maintenance for hematopoietic support co-culture systems |
rHSA for Xeno-Free and GMP Stem Cell Protocols
Recombinant Human Serum Albumin (rHSA) is the critical protein supplement for xeno-free and chemically defined stem cell culture systems — replacing animal-derived albumin with a defined, lot-consistent alternative. SeamlessBio supplies rHSA in three grades: Premium (rice-expressed, highest purity, GMP-grade), Economy (yeast-expressed, research use), and CHO-Expressed (mammalian glycosylation profile).
| Application | rHSA Grade | Concentration | Function |
|---|---|---|---|
| Xeno-free iPSC maintenance medium | Premium or Economy | 0.5–2 mg/mL | Albumin carrier for lipids and fatty acids — replaces bovine albumin in defined media without donor variability |
| GMP iPSC cryopreservation | Premium Grade | 4–10% in cryopreservation medium | Protein cryoprotectant — replaces FBS in xeno-free freezing protocols with defined composition |
| Feeder-free culture supplement | Economy (research) or Premium (GMP) | 0.1–1 mg/mL | Stabilises growth factors and protects cells from oxidative stress — no serum growth factors or undefined components |
| iPSC-CAR-T serum-free expansion | Premium Grade | 2–5 mg/mL | Albumin supplement in serum-free T cell expansion medium for clinical-grade iPSC-derived CAR-T products |
| Neural differentiation media | Economy Grade | 0.5–1 mg/mL | Protein stabiliser in N2/B27-supplemented serum-free neural differentiation medium |
Frequently Asked Questions
Request Free Test Volumes & Batch Reservation
FBS ES Cell Pre-Tested lot-specific pluripotency test reports available. rHSA Premium Grade samples for xeno-free protocol validation. Extended lot reservation for multi-year iPSC programmes on request.
Email: info@seamlessbio.de | +49 851 37932226
English 
Deutsch